Latest Conference Articles

Male sex and younger age are also risk factors for premature stent extrusion.

A Q&A with the medical director of clinical ophthalmology with Genentech about the humanized monoclonal antibody in treatment of NMOSD.

Discussing the impact of high-intensity statin therapy on patients with dry AMD with a study investigator from Byers Eye Institute.

Daniel Kiernan, MD, discusses the results of a study examining dexamethasone intracameral drug-delivery suspension compared with topical corticosteroids for inflammation following vitreoretinal surgery.

Investigators are evaluating the safety and tolerability of an optogenetic treatment combining a gene therapy and a medical device.

Discussing the latest data from Adverum Biotechnologies related to ADVM-022 and the ongoing phase 1 OPTIC trial with the trial's principal investigator.

Research from ARVO 2020 suggest a 4-minute educational video could more than double compliance with patching in pediatric patients with ambylopia.

Discussing how end of study results from the phase 2 LADDER trial inform clinicians on the use of PDS with ranibizumab.

An analysis suggests different regimens evaluated for nAMD did not result in superior vision benefits compared with ranibizumab pro re nata or four-week dosing.

New research suggests the prevalence of depression and anxiety is greater among patients with diabetic retinopathy.

A new analysis of STAIRWAY from ARVO 2020 is shedding additional light on the effects of faricimab use.

Children born to mothers who suffered from depression during pregnancy are at a greater risk of adolescent depression and psychosis.

There were no significant differences observed in mood episodes for bipolar patients in either AISR therapy or standard treatment.

Response does not favor more or less baseline symptom severity according to a new study.

Since 2005, opioid use has increased amongst older dementia patients.

Patients with adolescent disruption of cognitive developed had more severe symptoms following a schizophrenia diagnosis.

Investigators are currently working on a new algorithm that can present a time window in which an individual might develop suicidal behavior.

A meta-analysis of the online CBT programs shows promising benefits, with the addition of anonymity for patients.

Jesse Wright, MD, PhD, discusses the convenience of telehealth during the COVID-19 pandemic.

Jesse Wright, MD, PhD, suggests clinicians and patients have a list of triggers and social networks for patients who might be at risk of suicide.

In a virtual APA session, Nora D. Volkow, MD, discusses how vaping can increase the risk of individuals of developing infections from the coronavirus.

An expert projects annual national prevention lifeline calls will reach 3.7 million by 2023.

An analysis of 20-year outpatient prescribing trends show the drug class is being favored over mood stabilizers.

A look at the 3 stages of alcohol abuse and the state of mental health throughout it.

A look at how the antibody influences the pathology of encephalitis, and how it can be properly assessed and treated.

New research shows case fatality rates are increasing for individuals between 20-44 years old.

New federal regulations allows psychiatrists to use popular video conferencing tools like Zoom for telehealth appointments.

Investigators are still looking into the immediate and longterm effects of the virus on the mind.